Otros idiomas Protara Therapeutics, Inc.

Acciones

TARA

US74365U1079

Tiempo real estimado Cboe BZX Otros sitios de cotización 21:58:00 16/07/2024			Varia. Cinco días.	Varia. 1 de enero.
2,38 ^USD	0,00 %		+9,39 %	+24,26 %

02/05	Protara Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
05/04	Protara Therapeutics, Inc anuncia su alineación con la FDA sobre la vía de registro para el cloruro de colina intravenoso en pacientes dependientes de nutrición parenteral	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	24/06
Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit	21/05
Protara Therapeutics: Q1 Earnings Snapshot	02/05
Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update	02/05
Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors	30/04
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing	05/04
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Resignation of Jathin Bandari as Chief Medical Officer, Effective April 11, 2024	18/03
Protara Therapeutics: Q4 Earnings Snapshot	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	13/03
Proteon Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
North American Morning Briefing : Stock Futures -2-	13/03
Top Premarket Gainers	12/03
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Protara Therapeutics, Inc.

Acciones

TARA

US74365U1079

Otros idiomas

Filtros